Showing results (761-770 of 822) with videos related to
Sort By:
Pageof 83
The Journal of Clinical Investigation|April 28, 2022
Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody responseMaddalena Marconato, Irene A Abela, Anthony Hauser, et al.Emerging Infectious Diseases|November 21, 2020
Role of Oral Rabies Vaccines in the Elimination of Dog-Mediated Human Rabies DeathsRyan M Wallace, Florence Cliquet, Christine Fehlner-Gardiner, et al.Trials|October 22, 2021
A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®Benjamin Speich, Frédérique Chammartin, Daniel Smith, et al.Eclinicalmedicine|January 22, 2026
Cancer burden and risk factors among women with HIV: a multi-regional study from the D:A:D and RESPOND cohort collaborationsWin Min Han, Bastian Neesgaard, Michael Knappik, et al.Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|June 7, 2017
One Health contributions towards more effective and equitable approaches to health in low- and middle-income countriesS Cleaveland, J Sharp, B Abela-Ridder, et al.Frontiers in Genetics|April 29, 2015
Clinical, biochemical, and genetic spectrum of seven patients with NFU1 deficiencyUwe Ahting, Johannes A Mayr, Arnaud V Vanlander, et al.The Lancet. HIV|April 15, 2024
Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohortsDathan M Byonanebye, Mark N Polizzotto, Fernando Maltez, et al.Mbio|January 25, 2024
Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infectionIrene A Abela, Magdalena Schwarzmüller, Agne Ulyte, et al.Journal of Synchrotron Radiation|May 11, 2019
Experimental station Bernina at SwissFEL: condensed matter physics on femtosecond time scales investigated by X-ray diffraction and spectroscopic methodsGerhard Ingold, Rafael Abela, Christopher Arrell, et al.Plos One|January 24, 2025
Low agreement and frequent invalid controls in two SARS-CoV-2 T-cell assays in people with compromised immune functionAnnette Audigé, Alain Amstutz, Macé M Schuurmans, et al.Pageof 83